Back to results
US 2024/0190882 A1Published application
Crystalline Forms of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4,4-Dimethylpent-2-Enenitrile
AssigneePrincipia Biopharma Inc.
InventorsKolbot By, Mohammad R. Masjedizadeh, Pasit Phiasivongsa, Jiang Zhu
Life of this patent
Estimating the term…
Abstract
Crystalline forms of Compound (I): are disclosed. Pharmaceutical compositions comprising the same, methods of inhibiting BTK using the same, and methods for making crystalline forms of Compound (I) are also disclosed.
Claims49
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Crystalline Form (II) of Compound (I):
(canceled)
(canceled)
(canceled)
(canceled)
Crystalline Form (III) of Compound (I):
(canceled)
(canceled)
(canceled)
Crystalline Form (IV) of Compound (I):
(canceled)
(canceled)
Crystalline Form (V) of Compound (I):
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.